biofilm, immunology, culture
Academics Criticize University of Rochester’s Handling of Sexual Harassment Case
Academics Criticize University of Rochester’s Handling of Sexual Harassment Case
Shawna Williams | Nov 15, 2017
An open letter from hundreds of faculty members in the U.S. and abroad declares they won’t encourage students to pursue education or careers there.
Researchers Build a Cancer Immunotherapy Without Immune Cells
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena | Nov 13, 2017
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 
Ten-Minute Sabbatical
Ten-Minute Sabbatical
The Scientist Staff | Nov 1, 2017
Take a break from the bench to puzzle and peruse.
Dealing with Unethical or Illegal Conduct in Higher Education
Dealing with Unethical or Illegal Conduct in Higher Education
Anna Azvolinsky | Nov 1, 2017
Investigations into cases of wrongdoing by professors are increasingly in the public eye. But are colleges and universities doing enough to deal with the problem?
The Benefits of Trepidation
The Benefits of Trepidation
Abigail Marsh | Nov 1, 2017
While wiping fear from our brains may seem attractive, the emotion is an essential part of our behavioral repertoire.
2017 Life Science Salary Survey
2017 Life Science Salary Survey
Aggie Mika | Nov 1, 2017
Industry professionals make more than academic researchers, but for professors, it may not be about the money.
Salary Survey: By the Numbers
Salary Survey: By the Numbers
Aggie Mika | Oct 31, 2017
An overview of this year's results in graphical form
FDA Approves Second CAR T-Cell Therapy
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 
Compound Found in Red Wine Boosts Immune Cell Function
Compound Found in Red Wine Boosts Immune Cell Function
Catherine Offord | Oct 16, 2017
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling. 
Cancers Relapse by Feeding Off Immune Signals
Cancers Relapse by Feeding Off Immune Signals
Shawna Williams | Oct 16, 2017
In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.